Expression of the Multiple Sclerosis-Associated MHC Class II Allele HLA-DRB1*1501 Is Regulated by Vitamin D

Multiple sclerosis (MS) is a complex trait in which allelic variation in the MHC class II region exerts the single strongest effect on genetic risk. Epidemiological data in MS provide strong evidence that environmental factors act at a population level to influence the unusual geographical distribution of this disease. Growing evidence implicates sunlight or vitamin D as a key environmental factor in aetiology. We hypothesised that this environmental candidate might interact with inherited factors and sought responsive regulatory elements in the MHC class II region. Sequence analysis localised a single MHC vitamin D response element (VDRE) to the promoter region of HLA-DRB1. Sequencing of this promoter in greater than 1,000 chromosomes from HLA-DRB1 homozygotes showed absolute conservation of this putative VDRE on HLA-DRB1*15 haplotypes. In contrast, there was striking variation among non–MS-associated haplotypes. Electrophoretic mobility shift assays showed specific recruitment of vitamin D receptor to the VDRE in the HLA-DRB1*15 promoter, confirmed by chromatin immunoprecipitation experiments using lymphoblastoid cells homozygous for HLA-DRB1*15. Transient transfection using a luciferase reporter assay showed a functional role for this VDRE. B cells transiently transfected with the HLA-DRB1*15 gene promoter showed increased expression on stimulation with 1,25-dihydroxyvitamin D3 (P = 0.002) that was lost both on deletion of the VDRE or with the homologous “VDRE” sequence found in non–MS-associated HLA-DRB1 haplotypes. Flow cytometric analysis showed a specific increase in the cell surface expression of HLA-DRB1 upon addition of vitamin D only in HLA-DRB1*15 bearing lymphoblastoid cells. This study further implicates vitamin D as a strong environmental candidate in MS by demonstrating direct functional interaction with the major locus determining genetic susceptibility. These findings support a connection between the main epidemiological and genetic features of this disease with major practical implications for studies of disease mechanism and prevention.

[1]  C. Duijn,et al.  Genetic variation in the KIF1B locus influences susceptibility to multiple sclerosis , 2008, Nature Genetics.

[2]  C. Duijn,et al.  EVI5 is a risk gene for multiple sclerosis , 2008, Genes and Immunity.

[3]  M. Cantorna,et al.  The vitamin D receptor is required for iNKT cell development , 2008, Proceedings of the National Academy of Sciences.

[4]  G. Ebers Environmental factors and multiple sclerosis , 2008, The Lancet Neurology.

[5]  P. Menheere,et al.  Vitamin D as an immune modulator in multiple sclerosis, a review , 2008, Journal of Neuroimmunology.

[6]  G. Ebers,et al.  Genes for multiple sclerosis , 2008, The Lancet.

[7]  T. Hudson,et al.  An extremes of outcome strategy provides evidence that multiple sclerosis severity is determined by alleles at the HLA-DRB1 locus , 2007, Proceedings of the National Academy of Sciences.

[8]  S. Gabriel,et al.  Risk alleles for multiple sclerosis identified by a genomewide study. , 2007, The New England journal of medicine.

[9]  A. Morris,et al.  The Inheritance of Resistance Alleles in Multiple Sclerosis , 2007, PLoS genetics.

[10]  H. Harbo,et al.  Variation in interleukin 7 receptor alpha chain (IL7R) influences risk of multiple sclerosis. , 2007, Nature genetics.

[11]  A. Ascherio,et al.  Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. , 2006, JAMA.

[12]  C. Banwell,et al.  Regulation of the human p21(waf1/cip1) gene promoter via multiple binding sites for p53 and the vitamin D3 receptor , 2006, Nucleic acids research.

[13]  W. Reith,et al.  Regulation of MHC class II gene expression by the class II transactivator , 2005, Nature Reviews Immunology.

[14]  M. Z. Cader,et al.  Complex interactions among MHC haplotypes in multiple sclerosis: susceptibility and resistance. , 2005, Human molecular genetics.

[15]  P. Rothwell,et al.  Timing of birth and risk of multiple sclerosis: population based study , 2004, BMJ : British Medical Journal.

[16]  J. Hillert,et al.  Modes of action of HLA-DR susceptibility specificities in multiple sclerosis. , 2004, American journal of human genetics.

[17]  Wyeth W. Wasserman,et al.  JASPAR: an open-access database for eukaryotic transcription factor binding profiles , 2004, Nucleic Acids Res..

[18]  D. Kwiatkowski,et al.  Allele-specific repression of lymphotoxin-alpha by activated B cell factor-1. , 2004, Nature genetics.

[19]  N. Risch,et al.  Twin concordance and sibling recurrence rates in multiple sclerosis , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[20]  Tariq Ahmad,et al.  Haplotype-specific linkage disequilibrium patterns define the genetic topography of the human MHC. , 2003, Human molecular genetics.

[21]  Dominic P. Kwiatkowski,et al.  In vivo characterization of regulatory polymorphisms by allele-specific quantification of RNA polymerase loading , 2003, Nature Genetics.

[22]  M. Holick Vitamin D: A millenium perspective , 2003, Journal of cellular biochemistry.

[23]  G. Rosati,et al.  The worldwide prevalence of multiple sclerosis , 2002, Clinical Neurology and Neurosurgery.

[24]  B. Dawson-Hughes,et al.  Serum 25-hydroxyvitamin D status of adolescents and adults in two seasonal subpopulations from NHANES III. , 2002, Bone.

[25]  A. Abbas,et al.  The enemy within: keeping self-reactive T cells at bay in the periphery , 2002, Nature Reviews Immunology.

[26]  A. Kruger,et al.  Sequence analysis of the DRB1 promoter reveals limited polymorphism with no influence on gene expression , 2001, Genes and Immunity.

[27]  N. Jablonski,et al.  The evolution of human skin coloration. , 2000, Journal of human evolution.

[28]  N. Risch,et al.  Canadian Collaborative Project on Genetic Susceptibility to MS, Phase 2: Rationale and Method , 1998, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[29]  G. Andersson,et al.  Evolution of the human HLA-DR region. , 1998, Frontiers in bioscience : a journal and virtual library.

[30]  M. Elian,et al.  Age at immigration to England of Asian and Caribbean immigrants and the risk of developing multiple sclerosis , 1997, Journal of neurology, neurosurgery, and psychiatry.

[31]  F. Muntoni,et al.  Multiple sclerosis in Sardinia is associated and in linkage disequilibrium with HLA-DR3 and -DR4 alleles. , 1997, American journal of human genetics.

[32]  J. Hillert,et al.  The multiple sclerosis- and narcolepsy-associated HLA class II haplotype includes the DRB5*0101 allele. , 1995, Tissue antigens.

[33]  N. Risch,et al.  A genetic basis for familial aggregation in multiple sclerosis , 1995, Nature.

[34]  J. Herbert,et al.  High prevalence of vitamin D deficiency and reduced bone mass in multiple sclerosis , 1994, Neurology.

[35]  M. Waugh,et al.  Regulation of human monocyte HLA-DR and CD4 antigen expression, and antigen presentation by 1,25-dihydroxyvitamin D3. , 1990, Blood.

[36]  R. Russell,et al.  Constitutive and inducible expression of HLA class II determinants by human osteoblast-like cells in vitro. , 1990, The Journal of clinical investigation.

[37]  D. English,et al.  The epidemiology of multiple sclerosis in three Australian cities: Perth, Newcastle and Hobart. , 1988, Brain : a journal of neurology.

[38]  E. Acheson,et al.  SOME COMMENTS ON THE RELATIONSHIP OF THE DISTRIBUTION OF MULTIPLE SCLEROSIS TO LATITUDE, SOLAR RADIATION, AND OTHER VARIABLES , 1960, Acta psychiatrica Scandinavica. Supplementum.

[39]  W. L. Benedict,et al.  Multiple Sclerosis , 2007, Journal - Michigan State Medical Society.